Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.

Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...

Cyclists and bus users are subsidizing car drivers through sales taxes and property taxes: car drivers are freeloading on the ...

The documents published by the FSB include testimonies, photos, a certificate commemorating a badge earned in the Polish army ...

You feel like you have the flu, but you're not getting better Fever, chills, muscle aches and sleepiness are all classic signs of the common flu, or even Covid-19. But many people don't realize ...